中国药房Issue(32)：4523-4525,3.DOI:10.6039/j.issn.1001-0408.2015.32.21
北京地区氯诺昔康致不良反应48例分析
Analysis of 48 Cases of Lornoxicam-induced ADR in Beijing
崔喜凤 1邢丽秋 2马超 1张树荣 1李春钰1
作者信息
- 1. 北京丰台医院药剂科，北京 100071
- 2. 北京市药品不良反应监测中心，北京 100071
- 折叠
摘要
Abstract
OBJECTIVE:To investigate the characteristics and regularity of lornoxicam related ADR,and to provide reference for rational and safe use of lornoxicam. METHODS:From Jan. 1,2006 to Dec. 31,2013,lornoxicam related ADR reports collect-ed by National ADR Monitoring System in Beijing were analyzed retrospectively about their characteristics and related factors. RE-SULTS:In the statistical period,there were 48 ADR reports related to lornoxicam. The people over 40 years age accounted for 62.5%. 38 patients used lornoxicam by intravenous infusion or intramuscular injection ,accounting for 79.17%. The clinical mani-festations were diverse and complex,in which skin(32.96%)and gastrointestinal damage(25.00%)were more common ADR oc-curred within 30 min,accounting for 35.42%,and it would be better after stopping drug or 1-3 days symptomatic treatment. CON-CLUSIONS:The rational use of lornoxicam can reduce the occurrence of ADR. Suggestion on the use of the drug,is that the pa-tient should be monitored for security,in order to reduce the risk of ADR.关键词
氯诺昔康/不良反应/影响因素/安全性分析Key words
Lornoxicam/ADR/Influencing factors/Safety analysis分类
医药卫生引用本文复制引用
崔喜凤,邢丽秋,马超,张树荣,李春钰..北京地区氯诺昔康致不良反应48例分析[J].中国药房,2015,(32):4523-4525,3.
